The Øie–Tozer model of drug distribution and its suitability for drugs with different pharmacokinetic behavior

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.7, Iss.10, 2011-10, pp. : 1233-1243

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Physiologically-Based Pharmacokinetic Model of Drug Detoxification by Nanoparticles

By Fallon Marissa S. Varshney Manoj Dennis Donn M. Chauhan Anuj

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 31, Iss. 5, 2004-10 ,pp. : 381-400

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Significance of Pharmacokinetic Drug Interactions with Over-the-Counter (OTC) Drugs

By Honig P.K.

Clinical Pharmacokinetics, Vol. 35, Iss. 3, 1998-09 ,pp. : 167-171

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Changes of Drugs in Rat Model of Acute Renal Failure Induced by Uranyl Nitrate: Correlation Between Drug Metabolism and Hepatic Microsomal Cytochrome P450 Isozymes

Current Clinical Pharmacology, Vol. 1, Iss. 2, 2006-05 ,pp. : 193-205

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic Imaging: A Noninvasive Method for Determining Drug Distribution and Action

By Fischman A.J.

Clinical Pharmacokinetics, Vol. 41, Iss. 8, 2002-01 ,pp. : 581-602

Adis International

Access to resources Recommend Favorite

Preparation of fenofibrate nanosuspension and study of its pharmacokinetic behavior in rats

By Li XueMing Gu Li Xu YuanLong Wang YongLu

Drug Development and Industrial Pharmacy, Vol. 35, Iss. 7, 2009-07 ,pp. : 827-833

Informa Healthcare

Access to resources Recommend Favorite